Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of end-stage renal disease. These abnormalities occur within the first few years after the diagnosis of lupus is made on clinical grounds and with the support of laboratory tests in high risk patients. An early renal biopsy is helpful in patients with an abnormal urinalysis and/or reduced glomerular filtration rate and the results form the basis for therapeutic decisions. The biopsy also provides vital prognostic information based on histological categorization of different types of lupus nephritis, the degree of activity, chronicity and the immunopathogenesis. In the current armamentarium, the use of cyclophosphamide and azathioprine and recently mycophenolate mofetil, reduce morbidity and maintenance therapies reduce the risk of end-stage renal disease. Clinical trials underway promise new, effective and safe immunosuppressive regimens for the treatment of proliferative lupus nephritis.

Crop growth of maize (Zea mays L.) and Datura stramonium L. in monoculture and competition was studied over 4 years in a flood irrigated field in Zaragoza (Spain). Plant density was 8.33 m–2 for maize and 16.66 m–2 (1994 and 1995) and 8.33 m–2 (1996 and 1997) for D. stramonium. Maize yield was decreased by 14–63% when competing with the weed. Yield reduction increased as the time between crop and weed emergence decreased. The development of leaf area per plant during the exponential growth phase was faster in maize primarily because the leaf area of maize seedlings at emergence time was greater than that of the weed. The faster growth of maize in leaf area and height reduced the photosynthetically active radiation received by the weed. Datura stramonium had a lower radiation use efficiency (RUE) than maize. Competition from the weed slightly decreased the maximum leaf area index (LAI) of the crop, and leaf senescence of maize was accelerated. The weed competed with the crop late in the season reducing crop growth rate, grain number per ear and grain weight. Competitive ability of D. stramonium for light was mainly due to its growth habit, with the leaves concentrated in the upper part of the canopy (more than 75% of LAI in the upper 25% of its height), its higher light extinction coefficient (0.89) and its indeterminate growth habit. The N plant content of maize was not influenced by the presence of the weed. The weed had a higher N plant content than the crop throughout the season and took up more N in monoculture.

Complexome profiling is an emerging ‘omics approach that systematically interrogates the composition of protein complexes (the complexome) of a sample, by combining biochemical separation of native protein complexes with mass-spectrometry based quantitation proteomics. The resulting fractionation profiles hold comprehensive information on the abundance and composition of the complexome, and have a high potential for reuse by experimental and computational researchers. However, the lack of a central resource that provides access to these data, reported with adequate descriptions and an analysis tool, has limited their reuse. Therefore, we established the ComplexomE profiling DAta Resource (CEDAR, www3.cmbi.umcn.nl/cedar/), an openly accessible database for depositing and exploring mass spectrometry data from complexome profiling studies. Compatibility and reusability of the data is ensured by a standardized data and reporting format containing the “minimum information required for a complexome profiling experiment” (MIACE). The data can be accessed through a user-friendly web interface, as well as programmatically using the REST API portal. Additionally, all complexome profiles available on CEDAR can be inspected directly on the website with the profile viewer tool that allows the detection of correlated profiles and inference of potential complexes. In conclusion, CEDAR is a unique, growing and invaluable resource for the study of protein complex composition and dynamics across biological systems.

Treatment with nabumetone did not alter INR levels compared with placebo in patients stabilized on oral acenocoumarol who require NSAID therapy. These results suggest that nabumetone does not produce a clinically relevant interaction with acenocoumarol. In orally anticoagulated patients without other associated risk factors, treatment with nabumetone for up to 4 weeks does not require increased monitoring of INR levels.